Neuroleptic Malignant Syndrome with Antidepressant/Antipsychotic Drug Combination

Kaufmann CA Wyatt RJ . Neuroleptic malignant syndrome. In: Meltzer HY , ed. The third generation of progress in psychopharmacology. New York: Raven Press, 1987:185–202.

Caroff SN Mann SC . Neuroleptic malignant syndrome. Med Clin North Am 1993;77:185–202.

Lannas PA Pachar JV . A fatal case of neuroleptic malignant syndrome. Med Sci Law 1993;33:86–8.

Lane RM . SSRI-induced extrapyramidal side-effects and akathisia: Implications for treatment. J Clin Psychopharmacol 1998;12:192–214.

Caley CF . Extrapyramidal reactions and the selective serotonin-reuptake inhibitors. Ann Pharmacother 1997;31:1481–9.

Aisen PS Lawlor BA . Neuroleptic malignant syndrome induced by low-dose haloperidol (letter). Am J Psychiatry 1992;149:844.

McHugh TP . Neuroleptic malignant syndrome. J S C Med Assoc 1992;88:303–6.

Velamoor VR . NMS and haloperidol (abstract). Can J Psychiatry 1991;36:764.

Patkar AA Shah LP . Neuroleptic malignant sydrome. J Postgrad Med 1991;37:168–70.

Ganelin L Lichtenberg PS Marcus E Munter RG . Suspected neuroleptic malignant syndrome in a patient receiving clozapine. Ann Pharmacother 1996;30:248–50.

Sachdev P Kruk J Kneebone M Kissane D . Clozapine-induced neuroleptic malignant syndrome: Review and report of new cases. J Clin Psychopharmacol 1995;15:365–71.

Chatterton R Cardy S Schramm TM . Neuroleptic malignant syndrome and clozapine monotherapy. Aust N Z J Psychiatry 1996;30:692–3.

Karagianis JL Phillips LC Hogan K P LeDrew KK . Clozapine-associated neuroleptic malignant syndrome: Two new cases and a review of the literature. Ann Pharmacother 1999;33:623–30.

Naranjo CA Busto U Sellers EM Sandor P Ruiz I Roberts EA A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239–45.